The ANRS consolidates, coordinates, drives, and funds all public research in France on AIDS and viral hepatitis B and C. This includes basic, clinical, vaccine, and social sciences research. The ANRS also develops such research in resource-limited countries particularly affected by these diseases. From the outset, the ANRS has promoted multidisciplinarity and networks of researchers. As a research organization and funding body, the ANRS has great autonomy in its scientific policy-making and budget management.
The ANRS defines scientific priorities and mobilizes researchers of different institutions and disciplines through coordinated actions, which generate momentum in scientific deliberation and organization, team synergy, and new research projects.
The ANRS funds research projects and provides grants in all areas of HIV/AIDS and hepatitis research. Each year, the agency puts out two calls for research proposals, which, together with grant applications, are reviewed by international advisory boards and scientific committees. Overall, about one-third of submitted proposals or applications are approved and funded.
ANRS-funded projects yield scientific publications, which, depending on the year, rank second and third in the world for HIV/AIDS and viral hepatitis research, respectively, and approximately 7% of ANRS-supported publications are in the "top 1% of excellence." The ANRS is careful to promote the research results so that they benefit vulnerable populations affected by HIV/AIDS and viral hepatitis.